Study title: Novo-HelisenĀ® oral mite preparationsReport for PEI (PSUR) prepared (renewal of marketing authorisation). Age of patients: 6 - 80 Years
Type of medicine: Allergen extracts | |||||
Therapeutic area: Immune System Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: Dermatophagoids farinae;Dermatophagoides pteronyssinus | |||||
ATC code: V01AA03 | |||||
Document link: | |||||
Document date: | |||||
Study number: Retrospective data collection: 2004 (year) | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |